We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
+6.6%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$220M
AUM Growth
+$21.9M
Cap. Flow
+$60M
Cap. Flow %
27.25%
Top 10 Hldgs %
29.91%
Holding
89
New
19
Increased
34
Reduced
13
Closed
20

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$3.92M
2
ISRG icon
Intuitive Surgical
ISRG
+$3.35M
3
SYK icon
Stryker
SYK
+$3.29M
4
RMD icon
ResMed
RMD
+$2.29M
5
UHS icon
Universal Health Services
UHS
+$2.12M

Top Sells

Rank Stock Value
1
SHPG
Shire pic
SHPG
+$4.71M
2
VTRS icon
Viatris
VTRS
+$3.87M
3
ELV icon
Elevance Health
ELV
+$2.87M
4
CFN
CAREFUSION CORPORATION
CFN
+$2.66M
5
FRX
FOREST LABORATORIES INC
FRX
+$2.58M

Sector Composition

Rank Sector Weight
1 Healthcare 89.08%
2 Energy 0.53%
3 Industrials 0.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZTS icon
51
Zoetis
ZTS
$31.1B
$2.22M 1.01%
+60,000
New +$2.05M
AMED
52
DELISTED
Amedisys
AMED
$2.02M 0.92%
+100,000
New +$1.93M
PCYC
53
DELISTED
PHARMACYCLICS INC
PCYC
$1.76M 0.8%
+15,000
New +$1.71M
CBST
54
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
$1.66M 0.75%
25,000
+5,000
+25% +$328K
ILMN icon
55
Illumina
ILMN
$29.1B
$1.48M 0.67%
9,252
– –
PODD icon
56
Insulet
PODD
$10B
$1.47M 0.67%
40,000
+15,000
+60% +$548K
BMRN icon
57
BioMarin Pharmaceuticals
BMRN
$13.5B
$1.44M 0.66%
+20,000
New +$1.31M
NXTM
58
DELISTED
NxStage Medical Inc.
NXTM
$1.31M 0.6%
100,000
– –
INCY icon
59
Incyte
INCY
$24.5B
$1.23M 0.56%
+25,000
New +$1.25M
LHCG
60
DELISTED
LHC Group LLC
LHCG
$1.16M 0.53%
+50,000
New +$1.18M
SKH
61
DELISTED
SKILLED HEALTHCARE GROUP, INC. CLASS A COM STK
SKH
$833K 0.38%
+126,216
New +$827K
HMSY
62
DELISTED
HMS Holdings Corp.
HMSY
$788K 0.36%
+41,800
New +$846K
VIRX
63
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$520K 0.24%
347
+61
+21% +$88.3K
SPY icon
64
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$807B
$504K 0.23%
+150,000
New +$29.7M
CI icon
65
PUT
Cigna
CI
$72.4B
$67K 0.03%
+25,000
New +$2.34M
UNH icon
66
PUT
UnitedHealth
UNH
$365B
$64K 0.03%
+50,000
New +$4.23M
SYK icon
67
CALL
Stryker
SYK
$134B
$62K 0.03%
+50,000
New +$4.11M
DGX icon
68
CALL
Quest Diagnostics
DGX
$26.2B
$33K 0.02%
+50,000
New +$3.08M
BDX icon
69
CALL
Becton Dickinson
BDX
$49.4B
$26K 0.01%
+25,625
New +$2.92M
ACHC icon
70
Acadia Healthcare
ACHC
$2.9B
– –
-6,108
Closed -$278K
BDX icon
71
Becton Dickinson
BDX
$49.4B
– –
-11,864
Closed -$1.35M
CYH icon
72
CALL
Community Health Systems
CYH
$400M
– –
-60,500
Closed -$205K
DIA icon
73
PUT
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$48.2B
– –
-100,000
Closed -$130K
GMED icon
74
Globus Medical
GMED
$11.4B
– –
-49,538
Closed -$1.19M
GRFS
75
Grifois
GRFS
$5.44B
– –
-80,000
Closed -$1.76M
1 2
3
4

Similar funds

AFP
ATX Financial Planning Austin, Texas $132M AUM
TCPW
Twin City Private Wealth Winston-Salem, North Carolina $132M AUM 11.31% 1-Year Est. Return
PCGDR
Pangea Capital Gestao de Recursos Rio De Janeiro $131M AUM
ACM
Alcosta Capital Management San Ramon, California $131M AUM 34.7% 1-Year Est. Return
9C
9823 Capital Dallas, Texas $132M AUM
STFP
Signal Tree Financial Partners Copley, Ohio $132M AUM 15.43% 1-Year Est. Return
ADEF
ABS Direct Equity Fund Stamford, Connecticut $131M AUM 7.53% 1-Year Est. Return
AC
Aldebaran Capital Carmel, Indiana $131M AUM 34.7% 1-Year Est. Return

Sivik Global Healthcare's Q3 2014 Portfolio in Review

As of Q3 2014, Sivik Global Healthcare held 89 positions worth $220M, up 11% from $198M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Sivik Global Healthcare deployed $60M of net new capital in Q3 2014, opening 19 new positions and adding to 34 existing holdings. Its largest new stake was Amgen: 30,000 shares worth $4.21M.

By sector, the portfolio is most concentrated in Healthcare at 89% of assets, up from 88% a quarter earlier, followed by Energy and Industrials.

On the sell side, the largest reduction was Elevance Health, an estimated $2.87M trimmed.

  • Sivik Global Healthcare's largest Q3 2014 buy was Amgen: 30,000 shares worth $4.21M.
  • Sivik Global Healthcare added most to Universal Health Services in Q3 2014, an estimated $2.12M increase.
  • Sivik Global Healthcare's biggest Q3 2014 reduction was Elevance Health, cutting an estimated $2.87M.
  • Sivik Global Healthcare fully exited Shire pic in Q3 2014, selling an estimated $4.71M.
  • Sivik Global Healthcare's ten largest holdings make up 30% of its $220M portfolio in Q3 2014.
  • Sivik Global Healthcare opened 19 new positions and closed 20 in Q3 2014.
  • Sivik Global Healthcare's portfolio value rose 11% quarter-over-quarter to $220M.

Based on Sivik Global Healthcare's 13F filing for Q3 2014, filed 3 Oct 2014.